New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
OverviewChart

Quote Panel

Shape
Updated April 26, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape

  • Market Cap

  • Shares Outstanding

  • Share in Float

  • Dividende

  • Earning Date

    No Data

  • Price Target

  • Average Volume

  • Beta

  • Range

  • Industry

  • Website

  • Sector

Fundamentals

Shape

Relative Strength

Shape

NRXP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-1.30
vs -2.50

Q2.23

arrow
arrow

N/A

-1.20
vs -1.50

Q3.23

arrow
arrow

N/A

-0.70
vs -1.40

Q4.23

arrow
arrow

N/A

-0.50
vs -1.50

Q1.24

arrow
arrow

N/A

-0.74
vs -1.30

Q2.24

arrow
arrow

N/A

-0.75
vs -1.20

Q3.24

arrow
arrow

N/A

-0.15
vs -0.70

Q4.24

arrow
arrow

N/A

-0.30
vs -0.50

Q1.25

arrow
arrow

N/A

-0.30
vs -0.74

Q2.25

arrow
arrow

N/A

-0.15
vs -0.75

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

8K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 8K

Q1.25

arrow
arrow

NA

5M  vs NA

Q2.25

arrow
arrow

NA

10M  vs NA

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+4452%

44.52
vs -0.77

Q2.23

arrow
arrow

+310%

3.1
vs 44.52

Q3.23

arrow
arrow

+98%

0.98
vs 3.1

Q4.23

arrow
arrow

+37%

0.37
vs 0.98

Q1.24

arrow
arrow

+43%

0.43
vs 0.37

Q2.24

arrow
arrow

+43%

0.43
vs 0.43

Q3.24

arrow
arrow

+9%

0.09
vs 0.43

Q4.24

arrow
arrow

+39%

0.39
vs 0.09

Institutionnal OwnershipShape

status-upQoQ

Q2.19

arrow
arrow

16

16
vs 19

-16%

Q3.19

arrow
arrow

14

14
vs 16

-12%

Q4.19

arrow
arrow

12

12
vs 14

-14%

Q1.20

arrow
arrow

6

6
vs 12

-50%

Q2.20

arrow
arrow

5

5
vs 6

-17%

Q3.20

arrow
arrow

5

5
vs 5

NA

Q4.20

arrow
arrow

5

5
vs 5

NA

Q1.21

arrow
arrow

5

5
vs 5

NA

Earnings Growth

Latest News

NRXP

prnewswire.com

8 hours ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeuticsâ„¢, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
NRXP

prnewswire.com

8 hours ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
NRXP

prnewswire.com

8 hours ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics
NRXP

prnewswire.com

8 hours ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics
NRXP

zacks.com

10 hours ago

Here's Why NRx Pharmaceuticals (NRXP) Is a Great 'Buy the Bottom' Stock Now
NRXP

seekingalpha.com

10 hours ago

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript